Document Preview Unavailable

USP28 enables oncogenic transformation of respiratory cells and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K.

Prieto-Garcia, Cristian; Hartmann, Oliver; Reissland, Michaela; Braun, Fabian; Bozkurt, Sueleyman; et al.  bioRxiv, Sep 6, 2021.

You might have access to this document